Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority claimed from PCT/US1996/006814external-prioritypatent/WO1996040687A1/en
Publication of MXPA97008337ApublicationCriticalpatent/MXPA97008337A/en
Publication of MX9708337ApublicationCriticalpatent/MX9708337A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The [1:1] maleate salt of [R-(Z)]-1-Azabicyclo[2.2.1]heptan-3-one,O-[3-(3-methoxyphenyl)-2-propyny l]-oxime, a known muscarinic agonist has unique properties relative to other salts of the compound, rendering it a desirable pharmaceutical.
MX9708337A1996-05-131996-05-13(r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propyny l]oxime maleate as a pharmaceutical agent.
MX9708337A
(en)
A process for the preparation of a substituted dipeptide tartrate salt as growth hormone secretagogue, enantiomeric mixtures or their enantiomers, salt and compound.
L-tartaric acid salt of a(1r) diastereomer of a 2-azadihy-droxybicyclo [2.2.1]heptane compound and the preparation of 2-azabicyclo[2.2.1] heptane compounds